North American Morning Briefing : Big Banks Kick -2-	Apr. 12	DJ
North American Morning Briefing : Investors on -2-	Apr. 05	DJ
IPI Legacy Liquidation Co Went Out of Business	Apr. 05	CI
Second Revised First Amended Liquidation Plan Approved for IPI Legacy Liquidation Co	Apr. 02	CI
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
Impel Pharmaceuticals Inc. has Changed its Name to IPI Legacy Liquidation Co	Mar. 08	CI
Combined Disclosure Statement Conditionally Approved for Impel Pharmaceuticals Inc.	Feb. 26	CI
First Amended Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.	Feb. 25	CI
Impel Pharmaceuticals Inc. Announces Departure of Len Paolillo as Interim Chief Executive Officer	Feb. 14	CI
Joint Liquidation Plan and Disclosure Statement Filed by Impel Pharmaceuticals Inc.	Feb. 12	CI
An undisclosed buyer completed the acquisition of substantially all assets of Impel Pharmaceuticals Inc. for $17.5 million.	Feb. 11	CI
Motion for Asset Sale Approved for Impel Pharmaceuticals Inc.	Feb. 02	CI
Notice of Winning Bidder Filed by Impel Pharmaceuticals Inc.	Jan. 29	CI
Notice of Auction Cancellation Filed by Impel Pharmaceuticals Inc.	Jan. 26	CI
Bidding Procedure Approved for Impel Pharmaceuticals Inc.	Jan. 10	CI

Latest transcript on IPI Legacy Liquidation Co

23-05-12

Analyst Recommendations on IPI Legacy Liquidation Co

North American Morning Briefing : Investors on -2-	Apr. 05	DJ
North American Morning Briefing : Stocks Futures Steady on Rates Optimism	Nov. 20	DJ
Wall Street Set to Open Flat Friday as Investors Remain Wary of Potential Interest Rate Hike	23-09-08	MT
JonesTrading Downgrades Impel Pharmaceuticals to Hold From Buy	23-08-18	MT
Wedbush Adjusts Impel Pharmaceuticals' Price Target to $2 From $4, Maintains Neutral Rating	23-03-24	MT

Impel Pharmaceuticals : ORDER (I) APPROVING NOTIFICATION AND HEARING PROCEDURES FOR CERTAIN TRANSFERS OF AND DECLARATION OF WORTHLESSNESS WITH RESPECT TO COMMON STOCK AND (II) GRANTING RELATED RELIEF - Form 8-K	Jan. 02	PU
Impel Pharmaceuticals : Announces Filing Voluntary Chapter 11 Cases and Signing of "Stalking Horse" Agreement to Facilitate Sale - Form 8-K	Dec. 20	PU
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	23-10-05	GL
Impel Pharmaceuticals Announces Exploration of Strategic Alternatives	23-10-05	AQ
Thinking about buying stock in Workhorse Group, Canoo, Aurora Innovation, Plug Power, or Impel Pharmaceuticals?	23-07-05	PR

Managers	Title	Age	Since
John D. Hoekman FOU	Founder	43	07-12-31
Sheena Aurora CTO	Chief Tech/Sci/R&D Officer	-	-
Scott Youmans CTO	Chief Tech/Sci/R&D Officer	57	-

Members of the board	Title	Age	Since
Timothy Nelson BRD	Director/Board Member	60	17-01-31
Ali Satvat BRD	Director/Board Member	46	18-12-06
Diane Wilfong BRD	Director/Board Member	62	19-09-16

Name	Weight	AuM	1st Jan change	Investor Rating
LEVERAGE SHARES -3X SHORT BIOTECHNOLOGY ETP SECURITIES - USD	0.01%	0 M€	0.00%	-

IPI Legacy Liquidation Co, formerly Impel Pharmaceuticals Inc., is not engaged in any business operations. The Company doesnât hold any assets.

Sector

Calendar

	1st Jan change	Capi.
MODERNA, INC.	+21.74%	46.4B
IQVIA HOLDINGS INC.	-0.97%	41.75B
LONZA GROUP AG	+47.07%	41.37B
CELLTRION, INC.	-3.52%	29.71B
ICON PUBLIC LIMITED COMPANY	+11.12%	26.01B
ALNYLAM PHARMACEUTICALS, INC.	-19.37%	19.52B
MEDPACE HOLDINGS, INC.	+31.18%	12.43B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-0.04%	12.13B
BIO-TECHNE CORPORATION	+0.39%	12.18B